We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 12, 2014

AstraZeneca Pharmaceuticals LP et al v. Teva Pharmaceuticals USA Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. June 23, 2016

    Teva Agrees To Hold Off On Generic For Diabetes Drug Byetta

    Teva Pharmaceutical Industries Ltd. will be able to market a generic version of AstraZeneca’s diabetes drug Byetta by October 2017, according to a patent infringement settlement filed Thursday in Delaware federal court.


To view the parties, register now.